BNP Paribas Financial Markets’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$954K Sell
63,211
-145,502
-70% -$2.54M ﹤0.01% 3347
2026
Q1
$4M Sell
208,713
-1,039,768
-83% -$22.6M ﹤0.01% 2191
2025
Q4
$27.4M Buy
1,248,481
+1,028,866
+468% +$18.6M 0.01% 997
2025
Q3
$2.67M Sell
219,615
-142,263
-39% -$1.93M ﹤0.01% 2416
2025
Q2
$6.75M Sell
361,878
-97,920
-21% -$1.94M ﹤0.01% 1685
2025
Q1
$8.81M Buy
459,798
+434,979
+1,753% +$12.7M 0.01% 1474
2024
Q4
$894K Sell
24,819
-268,768
-92% -$9.09M ﹤0.01% 2904
2024
Q3
$12.5M Buy
293,587
+99,890
+52% +$4.24M 0.01% 1077
2024
Q2
$7.8M Buy
193,697
+47,885
+33% +$2M 0.01% 1202
2024
Q1
$5.16M Buy
145,812
+136,592
+1,481% +$3.66M ﹤0.01% 1442
2023
Q4
$273K Sell
9,220
-13,808
-60% -$286K ﹤0.01% 3100
2023
Q3
$478K Sell
23,028
-4,039
-15% -$111K ﹤0.01% 2750
2023
Q2
$664K Sell
27,067
-36,255
-57% -$1.17M ﹤0.01% 2432
2023
Q1
$2.57M Buy
63,322
+17,773
+39% +$736K ﹤0.01% 1655
2022
Q4
$2.05M Sell
45,549
-9,822
-18% -$445K ﹤0.01% 1743
2022
Q3
$2.65M Buy
55,371
+43,330
+360% +$2.38M ﹤0.01% 1747
2022
Q2
$713K Sell
12,041
-36,450
-75% -$2.99M ﹤0.01% 2438
2022
Q1
$5.64M Sell
48,491
-21,835
-31% -$2.55M 0.01% 1238
2021
Q4
$10.6M Buy
70,326
+63,873
+990% +$8.62M 0.02% 934
2021
Q3
$770K Sell
6,453
-16,273
-72% -$1.79M ﹤0.01% 2520
2021
Q2
$2.21M Sell
22,726
-71,465
-76% -$6.37M ﹤0.01% 1707
2021
Q1
$8.31M Buy
94,191
+87,365
+1,280% +$8.12M 0.01% 901
2020
Q4
$653K Buy
6,826
+5,121
+300% +$528K ﹤0.01% 2316
2020
Q3
$194K Sell
1,705
-10,510
-86% -$1.1M ﹤0.01% 2774
2020
Q2
$1.21M Sell
12,215
-77,622
-86% -$6.19M ﹤0.01% 1711
2020
Q1
$5.78M Buy
89,837
+81,969
+1,042% +$5.74M 0.01% 920
2019
Q4
$469K Sell
7,868
-2,239
-22% -$138K ﹤0.01% 2498
2019
Q3
$596K Buy
10,107
+2,778
+38% +$177K ﹤0.01% 2106
2019
Q2
$473K Sell
7,329
-4,548
-38% -$294K ﹤0.01% 2032
2019
Q1
$754K Buy
11,877
+10,921
+1,142% +$574K ﹤0.01% 1848
2018
Q4
$36.3K Sell
956
-1,009
-51% -$35.6K ﹤0.01% 2869
2018
Q3
$84.2K Buy
1,965
+503
+34% +$17.6K ﹤0.01% 2832
2018
Q2
$32.2K Buy
1,462
+1,459
+48,633% +$17.9K ﹤0.01% 3302
2018
Q1
$15 Hold
3
﹤0.01% 4186
2017
Q4
$7 Hold
3
﹤0.01% 4208
2017
Q3
$23 Hold
3
﹤0.01% 4185
2017
Q2
$25 Sell
3
-30
-91% -$277 ﹤0.01% 4208
2017
Q1
$391 Sell
33
-50
-60% -$1.09K ﹤0.01% 3886
2016
Q4
$1.79K Sell
83
-42
-34% -$1.62K ﹤0.01% 3936
2016
Q3
$9.56K Buy
125
+53
+74% +$3.87K ﹤0.01% 3181
2016
Q2
$5.43K Buy
+72
New +$5.8K ﹤0.01% 3235
2016
Q1
Sell
-178
Closed -$21K 3054
2015
Q4
$21K Sell
178
-221
-55% -$21.9K ﹤0.01% 2882
2015
Q3
$35.1K Buy
399
+252
+171% +$29.3K ﹤0.01% 3089
2015
Q2
$15.9K Buy
147
+128
+674% +$15.9K ﹤0.01% 3187
2015
Q1
$2.45K Buy
+19
New +$2.47K ﹤0.01% 3440
2014
Q4
Sell
-31
Closed -$4.16K 3087
2014
Q3
$4.16K Buy
+31
New +$4.34K ﹤0.01% 3852
2014
Q2
Sell
-2
Closed -$351 3942
2014
Q1
$351 Sell
2
-9
-82% -$2.29K ﹤0.01% 3113
2013
Q4
$2.91K Buy
+11
New +$2.52K ﹤0.01% 3447

Other funds holding TNDM

BNP Paribas Financial Markets's TNDM Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Tandem Diabetes Care (TNDM) stake by 70% in Q2 2026, selling an estimated $2.54M and leaving 63,211 shares worth $954K. The position accounts for ﹤0.01% of the portfolio, ranked #3347.

BNP Paribas Financial Markets first reported a position in TNDM in Q4 2013 and has held it in 48 quarters since. The position peaked at $27.4M in Q4 2025. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • BNP Paribas Financial Markets held 63,211 shares of Tandem Diabetes Care worth $954K as of Q2 2026.
  • BNP Paribas Financial Markets sold 145,502 Tandem Diabetes Care shares in Q2 2026, an estimated $2.54M.
  • Tandem Diabetes Care made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3347 holding.
  • BNP Paribas Financial Markets first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 48 quarters since.
  • BNP Paribas Financial Markets's Tandem Diabetes Care position peaked at $27.4M in Q4 2025.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.